Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

NCT02612506 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B， Chronic

Interventions

DRUG: Hepalatide
DRUG: Placebo

Sponsor

Shanghai HEP Pharmaceutical Co., Ltd.